Sanofi (SNY) Non-Current Debt (2009 - 2026)

Sanofi has disclosed Non-Current Debt across 18 years of filings, most recently posting $17.0 billion for Q2 2026.

• In Q2 2026, Non-Current Debt rose 13.93% year-over-year to $17.0 billion; the TTM figure through Jun 2026 stood at $17.0 billion (up 13.93% YoY), while the FY2025 annual figure was $16.6 billion, up 29.96% from the prior year.
• Non-Current Debt came in at $17.0 billion for Q2 2026 at Sanofi, up from $16.6 billion in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $17.0 billion in Q2 2026 to a low of $12.6 billion in Q4 2024.
• Average Non-Current Debt over 5 years is $15.3 billion, with a median of $15.4 billion recorded in 2023.
• Year-over-year, Non-Current Debt fell 22.62% in 2022 and surged 31.63% in 2025.
• Over 5 years, Non-Current Debt stood at $15.2 billion in 2022, then gained by 1.84% to $15.4 billion in 2023, then dropped by 18.38% to $12.6 billion in 2024, then surged by 31.63% to $16.6 billion in 2025, then gained by 2.64% to $17.0 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $17.0 billion in Q2 2026, $16.6 billion in Q4 2025, and $14.9 billion in Q2 2025.